human | Q5 |
P6178 | Dimensions author ID | 0713540153.74 |
P227 | GND ID | 173300413 |
P4359 | gravsted.dk ID | hansbisgaard |
P269 | IdRef ID | 059077808 |
P213 | ISNI | 0000000114621391 |
P244 | Library of Congress authority ID | n2001129307 |
P691 | NL CR AUT ID | nlk20040148003 |
P496 | ORCID iD | 0000-0003-4131-7592 |
P3829 | Publons author ID | 2216761 |
P1053 | ResearcherID | N-4761-2016 |
P214 | VIAF ID | 84856077 |
P10832 | WorldCat Entities ID | E39PBJppDxq63PvcVDvgw4fTHC |
P166 | award received | Novo Nordisk Prize | Q12329332 |
P27 | country of citizenship | Denmark | Q35 |
P1343 | described by source | Medvik | Q99413897 |
P108 | employer | University of Copenhagen | Q186285 |
P734 | family name | Bisgaard | Q37175352 |
Bisgaard | Q37175352 | ||
Bisgaard | Q37175352 | ||
P735 | given name | Hans | Q632842 |
Hans | Q632842 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q58877305 | Q58877305 |
Q57638160 | 17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestry |
Q51689448 | 17q21 gene variation is not associated with asthma in adulthood. |
Q57637870 | 17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use |
Q28818630 | 4th Pediatric Allergy and Asthma Meeting (PAAM) |
Q57638529 | A Clinical Comparison of Aerosol and Powder Administration of Beclomethasone Dipropionate in Childhood Asthma |
Q92082018 | A Protocol for Extraction of Infective Viromes Suitable for Metagenomics Sequencing from Low Volume Fecal Samples |
Q30399728 | A clinical pharmacology study of fixed vs. free combination of inhaled beclometasone dipropionate and formoterol fumarate dry powder inhalers in asthmatic adolescents |
Q41621173 | A functional IFN-λ4-generating DNA polymorphism could protect older asthmatic women from aeroallergen sensitization and associate with clinical features of asthma |
Q29417059 | A genome-wide association meta-analysis identifies new childhood obesity loci |
Q39455510 | A genome-wide association meta-analysis of diarrhoeal disease in young children identifies FUT2 locus and provides plausible biological pathways. |
Q24307696 | A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations |
Q52083301 | A mathematical model of aerosol holding chambers. |
Q57638449 | A metal aerosol holding chamber devised for young children with asthma |
Q36419271 | A new technique for ranking vascular corticosteroid effects in humans using laser-Doppler velocimetry |
Q34797065 | A non-electrostatic spacer for aerosol delivery |
Q35661744 | A novel common variant in DCST2 is associated with length in early life and height in adulthood |
Q57638136 | A novel method for assessing unchallenged levels of mediators in nasal epithelial lining fluid |
Q44198475 | A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis |
Q36300617 | A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma |
Q28327223 | A specific assay for leukotriene B4 in human whole blood |
Q90027807 | A trans-ancestral meta-analysis of genome-wide association studies reveals loci associated with childhood obesity |
Q90926802 | Abstract of the Scientific Literature |
Q53057157 | Accuracy of whole-body plethysmography requires biological calibration. |
Q39351534 | Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma. |
Q44466992 | Adrenal function in asthmatic children treated with inhaled budesonide |
Q57638496 | Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide |
Q46196254 | Aerosol particle size does not predict pharmacokinetic determined lung dose in children. |
Q36024565 | Age dependent systemic exposure to inhaled salbutamol |
Q101327694 | Airway immune mediator levels during asthma-like symptoms in young children and their possible role in response to azithromycin |
Q30366888 | Airway mucosal immune-suppression in neonates of mothers receiving A(H1N1)pnd09 vaccination during pregnancy. |
Q60917869 | Airway obstruction and bronchial reactivity from age 1 month until 13 years in children with asthma: A prospective birth cohort study |
Q34390950 | Alcohol intake in pregnancy increases the child's risk of atopic dermatitis. the COPSAC prospective birth cohort study of a high risk population |
Q57638486 | Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: Effect of the glucocorticoid budesonide |
Q51305633 | Allergic rhinitis is associated with otitis media with effusion: a birth cohort study. |
Q40404224 | Allergic sensitization at school age is a systemic low-grade inflammatory disorder. |
Q30430043 | Altered response to A(H1N1)pnd09 vaccination in pregnant women: a single blinded randomized controlled trial |
Q51893237 | Ambient air pollution triggers wheezing symptoms in infants. |
Q92513354 | Amplicon sequencing provides more accurate microbiome information in healthy children compared to culturing |
Q34579965 | An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children |
Q92347602 | Antibiotic exposure in infancy and development of BMI and body composition in childhood |
Q35015600 | Antibiotic use during pregnancy alters the commensal vaginal microbiota. |
Q39020502 | Antibiotics in Pregnancy Increase Children's Risk of Otitis Media and Ventilation Tubes |
Q41475589 | Assessment of bronchial hyperresponsiveness in preschool children: methodological issues |
Q39706515 | Association between allergic rhinitis and hospital resource use among asthmatic children in Norway |
Q100391923 | Association between childhood asthma and attention deficit hyperactivity or autism spectrum disorders: a systematic review with meta-analysis |
Q39014342 | Association between respiratory infections in early life and later asthma is independent of virus type |
Q47230040 | Association between whole-blood polyunsaturated fatty acids in pregnant women and early fetal weight |
Q90189076 | Association of Birth Weight With Type 2 Diabetes and Glycemic Traits: A Mendelian Randomization Study |
Q92413362 | Association of High-Dose Vitamin D Supplementation During Pregnancy With the Risk of Enamel Defects in Offspring: A 6-Year Follow-up of a Randomized Clinical Trial |
Q34176882 | Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study |
Q115027710 | Associations between Inhaled Corticosteroid Use in the First 6 Years of Life and Obesity-related Traits |
Q41104399 | Atopic endotype in childhood. |
Q62663196 | Author Correction: Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis |
Q53583076 | Automatic actuation of a dry powder inhaler into a nonelectrostatic spacer. |
Q40125516 | Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years: a randomised, double-blind, placebo-controlled trial |
Q43421339 | Bacteria-induced histamine release from human bronchoalveolar cells and blood leukocytes |
Q57638507 | Bioadhesive microspheres as a potential nasal drug delivery system |
Q38713410 | Bioenergetic Changes during Differentiation of Human Embryonic Stem Cells along the Hepatic Lineage |
Q57179429 | Biomarkers of exposure to environmental tobacco smoke in infants |
Q47581114 | Birth weight and risk of asthma in 3-9-year-old twins: exploring the fetal origins hypothesis |
Q40108600 | Bivariate genome-wide association meta-analysis of pediatric musculoskeletal traits reveals pleiotropic effects at the SREBF1/TOM1L2 locus |
Q41608875 | Blood lipid levels associate with childhood asthma, airway obstruction, bronchial hyperresponsiveness, and aeroallergen sensitization |
Q43596716 | Breast-feeding does not protect against allergic sensitization in early childhood and allergy-associated disease at age 7 years |
Q43681844 | Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer. |
Q54043857 | Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. |
Q39374605 | Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma |
Q50119806 | Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma |
Q39342252 | Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma |
Q47584947 | CDHR3 Genetics and Rhinovirus C Respiratory Illnesses |
Q38637485 | CDHR3 gene variation and childhood bronchiolitis. |
Q47442236 | Cat exposure in early life decreases asthma risk from the 17q21 high-risk variant |
Q45376298 | Causal direction between respiratory syncytial virus bronchiolitis and asthma studied in monozygotic twins |
Q57637922 | Cesarean Delivery and Body Mass Index at 6 Months and Into Childhood |
Q41752100 | Cesarean section and chronic immune disorders |
Q39863057 | Cesarean section changes neonatal gut colonization |
Q44942071 | Changes in body water distribution during treatment with inhaled steroid in pre-school children |
Q33633080 | Changes in risk of hospital readmission among asthmatic children in Denmark, 1978-93 |
Q57638521 | Chemotactic Activity of LTB4in Man |
Q44570200 | Childhood asthma after bacterial colonization of the airway in neonates |
Q92169316 | Children Monosensitized to Can f 5 Show Different Reactions to Male and Female Dog Allergen Extract Provocation: A Randomized Controlled Trial |
Q91210796 | Children with Asthma Have Fixed Airway Obstruction through Childhood Unaffected by Exacerbations |
Q44788743 | Children with allergic and nonallergic rhinitis have a similar risk of asthma |
Q50712545 | Children with asthma by school age display aberrant immune responses to pathogenic airway bacteria as infants. |
Q44053079 | Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. |
Q43406869 | Chronic Chlamydia pneumoniae lung infection: a neglected explanation for macrolide effects in wheezing and asthma? - Authors' reply |
Q37314296 | Classification of atopic hand eczema and the filaggrin mutations |
Q40552098 | Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort |
Q57638366 | Clinical effect of Diskus ™ dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children |
Q57638462 | Clinical efficacy of nebulized drugs |
Q34481975 | Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study |
Q40011366 | Coarse and fine particles but not ultrafine particles in urban air trigger hospital admission for asthma in children |
Q36317782 | Cold air challenge and specific airway resistance in preschool children |
Q28303063 | Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis |
Q37173595 | Common variants at 12q15 and 12q24 are associated with infant head circumference |
Q57638370 | Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics |
Q44610625 | Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide |
Q57285403 | Consortium genome-wide meta-analysis for childhood dental caries traits |
Q57278041 | Consortium-based genome-wide meta-analysis for childhood dental caries traits |
Q57638396 | Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic BronchopulmonaryPseudomonas aeruginosaInfection |
Q33748890 | Cord blood 25(OH)-vitamin D deficiency and childhood asthma, allergy and eczema: the COPSAC2000 birth cohort study |
Q57638104 | Cord blood Th2-related chemokine CCL22 levels associate with elevated total-IgE during preschool age |
Q97681290 | Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization |
Q43822447 | Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus babyhaler spacer in the treatment of asthma in preschool-aged children |
Q36066845 | Current concepts in chronic inflammatory diseases: Interactions between microbes, cellular metabolism, and inflammation |
Q57638045 | DENND1B gene variants associate with elevated exhaled nitric oxide in healthy high-risk neonates |
Q34534113 | Daily home measurements of exhaled nitric oxide in asthmatic children during natural birch pollen exposure |
Q60049124 | Data representations and -analyses of binary diary data in pursuit of stratifying children based on common childhood illnesses |
Q34154149 | Deep phenotyping of the unselected COPSAC2010 birth cohort study. |
Q37283122 | Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. |
Q98619141 | Delayed Motor Milestones Achievement in Infancy Associates with Perturbations of Amino Acids and Lipid Metabolic Pathways |
Q101573255 | Delivery mode and gut microbial changes correlate with an increased risk of childhood asthma |
Q41680896 | Delivery of inhaled medication to children |
Q57638401 | Delivery options for inhaled therapy in children under the age of 6 years |
Q57638405 | Demands on spacer devices for young children |
Q57638531 | Detection of leukotriene C4-like immunoreactivity in tear fluid from subjects challenged with specific allergen |
Q51763667 | Determinants of lung function and airway hyperresponsiveness in asthmatic children. |
Q63352920 | Determinants of neurodevelopment in early childhood – results from the copenhagen prospective studies on asthma in childhood ( COPSAC 2010 ) mother–child cohort |
Q57638220 | Development of Atopic Dermatitis During the First 3 Years of Life |
Q28646221 | Directional dominance on stature and cognition in diverse human populations |
Q57638053 | Disagreement between skin prick test and specific IgE in young children |
Q43718486 | Discriminative capacity of bronchodilator response measured with three different lung function techniques in asthmatic and healthy children aged 2 to 5 years |
Q89555296 | Distinct immune phenotypes in infants developing asthma during childhood |
Q53298738 | Divergent response profile in activated cord blood T cells from first-born child implies birth-order-associated in utero immune programming. |
Q39625929 | Domestic dog exposure at birth reduces the incidence of atopic dermatitis. |
Q43189977 | Drug delivery from inhaler devices |
Q57638467 | Duration of action of formoterol and salbutamol dry-powder inhalation in prevention of exercise-induced asthma in children |
Q41145869 | Duration of wheezy episodes in early childhood is independent of the microbial trigger |
Q54248155 | Early and late nasal symptom response to allergen challenge. The effect of pretreatment with a glucocorticosteroid spray. |
Q43112628 | Early bioavailability of inhaled salbutamol reflects lung dose in children |
Q40343821 | Early growth characteristics and the risk of reduced lung function and asthma: A meta-analysis of 25,000 children |
Q57637980 | Early indoor aeroallergen exposure is not associated with development of sensitization or allergic rhinitis in high-risk children |
Q96127845 | Ecological succession in the vaginal microbiota during pregnancy and birth |
Q61847253 | Effect modification of FADS2 polymorphisms on the association between breastfeeding and intelligence: results from a collaborative meta-analysis |
Q63352926 | Effect modification of FADS2 polymorphisms on the association between breastfeeding and intelligence: results from a collaborative meta-analysis |
Q38396701 | Effect of Vitamin D3 Supplementation During Pregnancy on Risk of Persistent Wheeze in the Offspring: A Randomized Clinical Trial |
Q34065347 | Effect of delivery device on systemic exposure to inhaled fluticasone propionate in children with asthma. |
Q36053350 | Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children |
Q58765784 | Effect of fish oil supplementation in pregnancy on bone, lean, and fat mass at six years: randomised clinical trial |
Q35052196 | Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans |
Q35547844 | Effect of long‐acting β2 agonists on exacerbation rates of asthma in children |
Q35804135 | Effect of plastic spacer handling on salbutamol lung deposition in asthmatic children |
Q57638532 | Effects of Leukotrienes on Neutrophil Migration, and on Production and Action of Lymphokines |
Q35047399 | Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation |
Q44173733 | Effects of synthetic leukotriene D-4 on the local regulation of blood flow in human subcutaneous tissue |
Q51701536 | Efficacy of steroid treatments in the asthmatic preschool child. |
Q39840885 | Eicosanoids in skin UV inflammation. |
Q57638145 | Elevated Exhaled Nitric Oxide in High-Risk Neonates Precedes Transient Early but Not Persistent Wheeze |
Q44774754 | Elevated eosinophil protein X in urine from healthy neonates precedes development of atopy in the first 6 years of life |
Q57637799 | Endotyping early childhood asthma by quantitative symptom assessment |
Q90877597 | Environmental and Genetic Determinants of Serum 25(OH)-Vitamin D Levels during Pregnancy and Early Childhood |
Q61788420 | Environmental grass pollen levels in utero and at birth and cord blood IgE: Analysis of three birth cohorts |
Q57637875 | Epidemiology and Risk Factors of Infection in Early Childhood |
Q59273847 | Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation |
Q57105402 | Erratum: Common variants at 12q15 and 12q24 are associated with infant head circumference |
Q58673336 | Evidence-based medicines for children: ethical aspects |
Q47707099 | Exhaled nitric oxide predicts exercise-induced bronchoconstriction in asthmatic school children |
Q57638363 | Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine |
Q45385977 | Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study |
Q46714696 | Extrapolating evidence beyond age groups |
Q107295393 | FUT2-ABO epistasis increases the risk of early childhood asthma and Streptococcus pneumoniae respiratory illnesses |
Q50543983 | Fatty acid composition of human milk in atopic Danish mothers. |
Q47713287 | FeNO and Exercise Testing in Children at Risk of Asthma |
Q43545273 | FeNO measured at fixed exhalation flow rate during controlled tidal breathing in children from the age of 2 yr. |
Q46939010 | Feasibility of repetitive lung function measurements by raised volume rapid thoracoabdominal compression during methacholine challenge in young infants |
Q44391232 | Filaggrin gene variants and atopic diseases in early childhood assessed longitudinally from birth |
Q57401969 | Filaggrin loss-of-function mutation R501X and 2282del4 carrier status is associated with fissured skin on the hands: results from a cross-sectional population study |
Q57638194 | Filaggrin null alleles are not associated with hand eczema or contact allergy |
Q57638373 | Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma |
Q63352924 | Fish Oil Supplementation in Pregnancy Increases Gestational Age, Size for Gestational Age, and Birth Weight in Infants: A Randomized Controlled Trial |
Q40393057 | Fish Oil-Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring |
Q92938800 | Fish oil supplementation during pregnancy is protective against asthma/wheeze in offspring |
Q92532988 | Fish-oil supplementation in pregnancy, child metabolomics and asthma risk |
Q57638410 | Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizerfi |
Q45107389 | Fraction of exhaled nitric oxide and bronchial responsiveness are associated and continuous traits in young children independent of asthma. |
Q35101852 | Fraction of exhaled nitric oxide values in childhood are associated with 17q11.2-q12 and 17q12-q21 variants |
Q40804028 | Future options for aerosol delivery to children |
Q91995911 | GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI |
Q21090137 | Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure |
Q36738318 | Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight |
Q57285419 | Genetic architecture of early childhood growth phenotypes gives insights into their link with later obesity |
Q109309625 | Genetic association study of childhood aggression across raters, instruments, and age |
Q36470362 | Genetic associations with viral respiratory illnesses and asthma control in children. |
Q63352925 | Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood |
Q30313778 | Genome-wide analysis identifies 12 loci influencing human reproductive behavior |
Q36861322 | Genome-wide association analysis identifies three new susceptibility loci for childhood body mass index |
Q57136958 | Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis |
Q34330305 | Genome-wide association and longitudinal analyses reveal genetic loci linking pubertal height growth, pubertal timing and childhood adiposity |
Q34046898 | Genome-wide association study identifies 74 loci associated with educational attainment |
Q57285441 | Genome-wide association study of offspring birth weight in 86,577 women highlights maternal genetic effects that are independent of fetal genetics |
Q47172157 | Genome-wide association study of offspring birth weight in 86,577 women identifies five novel loci and highlights maternal genetic effects that are independent of fetal genetics |
Q34678968 | Genome-wide associations for birth weight and correlations with adult disease |
Q44680438 | Heterogeneity of FeNO response to inhaled steroid in asthmatic children |
Q50634605 | High breast milk IL-1β level is associated with reduced risk of childhood eczema. |
Q63352919 | High-Dose Vitamin D Supplementation During Pregnancy and Asthma in Offspring at the Age of 6 Years |
Q57638483 | Histamine release after nasal challenge with anti-IgE and Staphylococcus aureus in patients with allergic rhinitis |
Q57638534 | Human Leukocyte Cyclic AMP and Cyclic GMP Levels during Chemotaxis in Delayed Type Hypersensitivity |
Q57638544 | Human leukocyte mobilization and morphology in nickel contact allergy using a skin chamber technique |
Q47896233 | Hyperventilation with cold versus dry air in 2- to 5-year-old children with asthma. |
Q30359016 | Immune-mediated diseases and microbial exposure in early life. |
Q54441825 | Impact of constant and breath-synchronized nebulization on inhaled mass of nebulized budesonide in infants and children. |
Q39377916 | In utero exposure to 25-hydroxyvitamin D and risk of childhood asthma, wheeze, and respiratory tract infections: A meta-analysis of birth cohort studies. |
Q57638374 | In vitro performance of three combinations of spacers and pressurized metered dose inhalers for treatment in children |
Q36201101 | Incidence and Determinants of Ventilation Tubes in Denmark |
Q45396812 | Increased concordance of severe respiratory syncytial virus infection in identical twins |
Q57638149 | Increased risk of eczema but reduced risk of early wheezy disorder from exclusive breast-feeding in high-risk infants |
Q35007251 | Increased risk of pneumonia and bronchiolitis after bacterial colonization of the airways as neonates. |
Q57401959 | Individuals who are homozygous for the 2282del4 and R501X filaggrin null mutations do not always develop dermatitis and complete long-term remission is possible |
Q45336681 | Infant acetaminophen use associates with early asthmatic symptoms independently of respiratory tract infections: the Copenhagen Prospective Study on Asthma in Childhood 2000 (COPSAC(2000)) cohort. |
Q91062522 | Infant airway microbiota and topical immune perturbations in the origins of childhood asthma |
Q48920350 | Inhaled budesonide for treatment of recurrent wheezing in early childhood |
Q57638109 | Interaction between Asthma and Lung Function Growth in Early Life |
Q92252602 | Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis |
Q57638228 | Intermittent Inhaled Corticosteroids in Infants with Episodic Wheezing |
Q33714840 | Investigating the causal effect of smoking on hay fever and asthma: a Mendelian randomization meta-analysis in the CARTA consortium |
Q38778453 | Knemometry is more sensitive to systemic effects of inhaled corticosteroids in children with asthma than 24-hour urine cortisol excretion |
Q44615194 | Lactoferrin, myeloperoxidase, lysozyme and eosinophil cationic protein in exudate in delayed type hypersensitivity |
Q31144565 | Large-scale benchmarking reveals false discoveries and count transformation sensitivity in 16S rRNA gene amplicon data analysis methods used in microbiome studies. |
Q36420601 | Laser Doppler flowmeter |
Q41364137 | Leukotriene B4 produces hyperalgesia in humans |
Q44694150 | Leukotriene C4 and histamine in early allergic reaction in the nose |
Q36594216 | Leukotriene D4 increases nasal blood flow in humans |
Q57638541 | Leukotriene D4 induces bronchoconstriction in man |
Q31832775 | Leukotriene modifiers in pediatric asthma management |
Q57638526 | Leukotriene- and Histamine-Induced Increases in Vascular Permeability and Interstitial Transport in the Skin |
Q57638537 | Leukotrienes and Prostaglandins in Asthma |
Q45275478 | Leukotrienes in allergic and inflammatory conditions |
Q33937511 | Leukotrienes, leukotriene receptor antagonists, and rhinitis |
Q44096298 | Levalbuterol has not been established to have therapeutic advantage over racemic albuterol |
Q63352921 | Levels of Systemic Low-grade Inflammation in Pregnant Mothers and Their Offspring are Correlated |
Q47229547 | Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects |
Q59132776 | Limited clinical value of exhaled volatile organic compound measurements in childhood asthma |
Q31104585 | Living with cat and dog increases vaginal colonization with E. coli in pregnant women |
Q43073812 | Loci for primary ciliary dyskinesia map to chromosome 16p12.1-12.2 and 15q13.1-15.1 in Faroe Islands and Israeli Druze genetic isolates. |
Q33844342 | Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature |
Q57638231 | Long-acting β2 agonists and paediatric asthma |
Q45096477 | Long-term exposure to indoor air pollution and wheezing symptoms in infants |
Q37778126 | Long-term studies of the natural history of asthma in childhood |
Q43938380 | Longitudinal study of lung function in a cohort of primary ciliary dyskinesia |
Q61124883 | Low-frequency variation in TP53 has large effects on head circumference and intracranial volume |
Q57315734 | Low-frequency variation inTP53has large effects on head circumference and intracranial volume |
Q57638307 | Lung Deposition of Inhaled Drugs Increases with Age |
Q34798502 | Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma |
Q54535598 | Lung function and bronchial responsiveness after Mycoplasma pneumoniae infection in early childhood. |
Q54068828 | Lung function and short-term outcome in young asthmatic children. |
Q54156102 | Lung function measurement in awake young children. |
Q54048303 | Lung function response to cold air challenge in asthmatic and healthy children of 2-5 years of age. |
Q61852669 | Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors |
Q64109834 | Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors |
Q43557844 | Maternal antibiotic use and risk of asthma in offspring--Authors' reply |
Q57578180 | Maternal fatty acid desaturase genotype correlates with infant immune responses at 6 months |
Q38419548 | Maternal propensity for infections and risk of childhood asthma: a registry-based cohort study |
Q44058564 | Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood |
Q48267558 | Maturation of the gut microbiome and risk of asthma in childhood |
Q71309341 | Measurement of lung function in awake 2-4-year-old asthmatic children during methacholine challenge and acute asthma: a comparison of the impulse oscillation technique, the interrupter technique, and transcutaneous measurement of oxygen versus whole |
Q57638444 | Measurement of lung function in awake 2–4‐year‐old asthmatic children during methacholine challenge and acute asthma: A comparison of the impulse oscillation technique, the interrupter technique, and transcutaneous measurement of oxygen versus |
Q57638498 | Measurement of secretion in nasal lavage |
Q33486913 | Measurement of the specific airway resistance by plethysmography in young children accompanied by an adult |
Q34424366 | Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years |
Q94557211 | Mendelian randomization analysis does not support causal associations of birth weight with hypertension risk and blood pressure in adulthood |
Q34354830 | Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization |
Q24596087 | Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis |
Q57578203 | Metagenomic heterogeneity explains dual immune effects of endotoxins |
Q36351758 | Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial |
Q44758270 | Montelukast in RSV-bronchiolitis |
Q53516366 | Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). |
Q45150106 | Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma |
Q43726631 | Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years |
Q36580238 | Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis |
Q47218106 | Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. |
Q63352923 | Multiple Breath Washout for Diagnosing Asthma and Persistent Wheeze in Young Children |
Q57637880 | NKG2D gene variation and susceptibility to viral bronchiolitis in childhood |
Q57638323 | NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast |
Q57638381 | Nasal inhalation of budesonide from a spacer in children with perennial rhinitis and asthma |
Q57638511 | Nebulization and selective deposition of LTD4in human lungs |
Q90132796 | Neonatal Urine Metabolic Profiling and Development of Childhood Asthma |
Q45344776 | Neonatal airway colonization is associated with troublesome lung symptoms in infants. |
Q51353088 | Neonatal bronchial hyperresponsiveness precedes acute severe viral bronchiolitis in infants. |
Q51850879 | Neonatal colonization with Staphylococcus aureus is not associated with development of atopic dermatitis. |
Q40306192 | Neonatal cytokine profile in the airway mucosal lining fluid is skewed by maternal atopy |
Q47323857 | Neonatal size in term children is associated with asthma at age 7, but not with atopic dermatitis or allergic sensitization. |
Q54091665 | Neonates colonized with pathogenic bacteria in the airways have a low-grade systemic inflammation. |
Q41550475 | Neonates with reduced neonatal lung function have systemic low-grade inflammation |
Q36708957 | New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism |
Q35045075 | New parameters for evaluation of blood flow in patients with leg ulcers. |
Q50686744 | New time-saving predictor algorithm for multiple breath washout in adolescents. |
Q57637952 | No evidence of intrauterine sensitization against inhalant allergens |
Q47801514 | Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels |
Q100523202 | Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits |
Q55050509 | ORMDL3 variants associated with asthma susceptibility in North Americans of European ancestry. |
Q45802748 | Objective assessment of levels and patterns of physical activity in preschool children. |
Q57638168 | Objective assessments of allergic and nonallergic rhinitis in young children |
Q52926084 | Observer variability of lung function measurements in 2-6-yr-old children. |
Q92530860 | Optimal timing of influenza vaccine during pregnancy: A systematic review and meta-analysis |
Q57638491 | PEP-spacer: an adaptation for administration of MDI to infants |
Q97429456 | Parent-specific effects on risk of developing allergic sensitization and asthma in childhood |
Q46326414 | Pathogenic bacteria colonizing the airways in asymptomatic neonates stimulates topical inflammatory mediator release |
Q40275065 | Perceptions of parents on the participation of their infants in clinical research. |
Q57638299 | Persistent Wheezing in Very Young Preschool Children Reflects Lower Respiratory Inflammation |
Q92712510 | Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation |
Q36729964 | Pharmacokinetic comparison of inhaled fixed combination vs. the free combination of beclomethasone and formoterol pMDIs in asthmatic children |
Q57638155 | Physical activity in young children is reduced with increasing bronchial responsiveness |
Q37223596 | Picornavirus-Induced Airway Mucosa Immune Profile in Asymptomatic Neonates |
Q36186186 | Plethysmographic measurements of specific airway resistance in young children. |
Q57638115 | Polyunsaturated fatty acid content of mother’s milk is associated with childhood body composition |
Q43960852 | Postmenopausal hormone therapy and asthma-related hospital admission |
Q47764932 | Precision allergy: Separate allergies to male and female dogs |
Q46177267 | Predicting an asthma exacerbation in children 2 to 5 years of age. |
Q50552327 | Predictors of indoor fine particulate matter in infants' bedrooms in Denmark. |
Q39391740 | Preeclampsia Associates with Asthma, Allergy, and Eczema in Childhood |
Q57578183 | Prelabor cesarean section bypasses natural immune cell maturation |
Q57637884 | Prenatal Vitamin D Supplementation to Improve Health in Offspring |
Q51721704 | Prenatal and postnatal genetic influence on lung function development. |
Q46157508 | Prenatal determinants of neonatal lung function in high-risk newborns |
Q92860064 | Prenatal dietary supplements influence the infant airway microbiota in a randomized factorial clinical trial |
Q44871600 | Prenatal vitamin D supplementation reduces risk of asthma/recurrent wheeze in early childhood: A combined analysis of two randomized controlled trials |
Q33624484 | Preterm birth, infant weight gain, and childhood asthma risk: a meta-analysis of 147,000 European children |
Q35067912 | Prevalence and predictors of antibiotic administration during pregnancy and birth |
Q57638206 | Prevalence of asthma-like symptoms in young children |
Q57638527 | Production of Leukotrienes in Human Skin and Conjunctival Mucosa after Specific Allergen Challenge |
Q57638538 | Production of peptido-lipid leukotrienes in human tear fluid following antigen challenge |
Q91210748 | Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expression |
Q30352766 | Public hygiene campaign in denmark during the 2009 H1N1 pandemic had no effect on hospitalization rate of communicable diseases in children. |
Q49599891 | Publisher Correction: Maturation of the gut microbiome and risk of asthma in childhood |
Q36606938 | Quantitation of microcirculatory blood flow changes in human cutaneous tissue induced by inflammatory mediators |
Q112575786 | Rare variant analysis in eczema identifies exonic variants in DUSP1, NOTCH4 and SLC9A4 |
Q38668126 | Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium |
Q64996201 | Reduced IL-2 response from peripheral blood mononuclear cells exposed to bacteria at 6 months of age is associated with elevated total-IgE and allergic rhinitis during the first 7 years of life. |
Q117654161 | Reduced Steroid Metabolites Identify Infection-Prone Children in Two Independent Pre-Birth Cohorts |
Q51019555 | Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. |
Q57638421 | Repeatability of methacholine challenges in 2 to 4-year-old children with asthma, using a new technique for quantitative delivery of aerosol |
Q43983645 | Reply: Allergy is not always the cause of asthma |
Q37617751 | Respiratory medicines for children: current evidence, unlicensed use and research priorities |
Q43759190 | Response of preschool children with asthma symptoms to fluticasone propionate |
Q44409436 | Response to montelukast among subgroups of children aged 2 to 14 years with asthma |
Q37128812 | Rhinovirus wheezing illness and genetic risk of childhood-onset asthma |
Q57638514 | Risk Factors for Wheezing during Infancy A Study of 5953 Infants |
Q45980533 | Risk analysis of early childhood eczema. |
Q38410012 | Risk of Asthma from Cesarean Delivery Depends on Membrane Rupture |
Q33949879 | Robustness of genome-wide scanning using archived dried blood spot samples as a DNA source |
Q33988564 | Role of leukotrienes in asthma pathophysiology |
Q57638504 | SRS-A leukotrienes decrease the activity of human respiratory cilia |
Q47649736 | Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial |
Q37486326 | Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions |
Q41266854 | Safety of treatment |
Q51572995 | Season of birth shapes neonatal immune function. |
Q40342982 | Sensitivity of bronchial responsiveness measurements in young infants |
Q63352922 | Sensitivity of multiple breath washout to detect mild-to-moderate asthma in adolescence |
Q57637827 | Sensitization does not develop in utero |
Q38738987 | Sensitization trajectories in childhood revealed by using a cluster analysis |
Q48005271 | Serial lung function and responsiveness in cystic fibrosis during early childhood. |
Q57638172 | Seven-year-old children's perceptions of participating in a comprehensive clinical birth cohort study |
Q38966298 | Shared genetic variants suggest common pathways in allergy and autoimmune diseases |
Q60313071 | Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial |
Q40952282 | Siblings Promote a Type 1/Type 17-oriented immune response in the airways of asymptomatic neonates |
Q57638326 | Simultaneous treatment of rhinitis and asthma by nasal inhalation of corticosteroid from a spacer |
Q91829278 | Single and multiple time-point allergic sensitization during childhood and risk of asthma by age 13 |
Q57401938 | Skin barrier abnormality caused by filaggrin (FLG) mutations is associated with increased serum 25-hydroxyvitamin D concentrations |
Q57638385 | Specific airway resistance, interrupter resistance, and respiratory impedance in healthy children aged 2–7 years |
Q41489976 | Stable admission rate for acute asthma in Danish children since 1977. |
Q45847184 | Staphylococcus aureus and influenza A virus stimulate human bronchoalveolar cells to release histamine and leukotrienes |
Q45394161 | Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children |
Q38618496 | Sulphidoleukotrienes in human allergic diseases |
Q35801433 | Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma |
Q38903936 | Susceptibility to Lower Respiratory Infections in Childhood is Associated with Perturbation of the Cytokine Response to Pathogenic Airway Bacteria. |
Q43903325 | Systemic activity of inhaled steroids in 1- to 3-year-old children with asthma |
Q57638479 | Systemic activity of inhaled topical steroid in toddlers studied by knemometry |
Q53510181 | Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent. |
Q57638277 | THE ROLE OF INFECTIONS IN PEDIATRIC ASTHMA |
Q57638389 | Targeting drugs to the respiratory tract |
Q57638176 | The Brussels Declaration: the need for change in asthma management |
Q30974948 | The Copenhagen Prospective Study on Asthma in Childhood (COPSAC): design, rationale, and baseline data from a longitudinal birth cohort study |
Q57638329 | The Effect of Inhaled Fluticasone Propionate in the Treatment of Young Asthmatic Children |
Q114082709 | The Maternal Prenatal and Offspring Early‐Life Gut Microbiome of Childhood Asthma Phenotypes |
Q47673585 | The PCDH1 gene and asthma in early childhood |
Q40503150 | The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts |
Q45387480 | The causal direction in the association between respiratory syncytial virus hospitalization and asthma |
Q37547143 | The developing hypopharyngeal microbiota in early life |
Q54033764 | The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children. |
Q36648846 | The effect of leukotriene C4 and D4 on cutaneous blood flow in humans |
Q36634118 | The effect of leukotrienes C4 and D4 on microcirculatory flow in humans. |
Q57638540 | The possible role of LTD4 in asthma in humans investigated in vivo |
Q92795272 | The role of the 17q21 genotype in the prevention of early childhood asthma and recurrent wheeze by vitamin D |
Q46460710 | The systemic exposure to inhaled beclometasone/formoterol pMDI with valved holding chamber is independent of age and body size. |
Q57638332 | Towards improved aerosol devices for the young child |
Q39841095 | Transfer of maternal IgE can be a common cause of increased IgE levels in cord blood |
Q44750425 | Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing |
Q36086956 | Understanding mild persistent asthma in children: the next frontier |
Q57638132 | Upper and Lower Airway Patency Are Associated in Young Children |
Q42287087 | Use of antibiotics during pregnancy increases the risk of asthma in early childhood |
Q57638472 | Use of budesonide Turbuhaler® in young children suspected of asthma |
Q41605009 | Use of inhaled corticosteroids in pediatric asthma |
Q50761172 | VEGFA variants are associated with pre-school lung function, but not neonatal lung function. |
Q45472645 | Validation of a pediatric caregiver diary to measure symptoms of postacute respiratory syncytial virus bronchiolitis |
Q34454067 | Validity of information on atopic disease and other illness in young children reported by parents in a prospective birth cohort study |
Q57285390 | Variants in the fetal genome near pro-inflammatory cytokine genes on 2q13 are associated with gestational duration |
Q93064046 | Variants in the fetal genome near pro-inflammatory cytokine genes on 2q13 associate with gestational duration |
Q34089817 | Variants of DENND1B associated with asthma in children |
Q57638255 | Variations in Pediatric Asthma Hospitalization Rates and Costs Between and Within Nordic Countries |
Q36482367 | Vascular effects of leukotriene D4 in human skin |
Q114865142 | Vertical Transfer of Metabolites Detectable from Newborn’s Dried Blood Spot Samples Using UPLC-MS: A Chemometric Study |
Q92739733 | Virulent coliphages in 1-year-old children fecal samples are fewer, but more infectious than temperate coliphages |
Q57638427 | What dose fraction represents the respirable dose? |
Q57638210 | What drives prescription patterns in pediatric asthma management? |
Q90308433 | Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children With Asthma |
Q50559512 | [Childhood asthma: Danish guidelines for diagnosis and treatment]. |
Q57638474 | [Formoterol--a prolonged-action beta 2 agonist] |
Q57638241 | [No risk of development of osteoporosis or inhibition of growth in children with asthma treated with inhaled corticosteroids] |
Q57638289 | [Pediatric pulmonology] |
Q57638392 | [Steroid treatment of asthmatic children] |
Q57638518 | [The Marstock method. A method for measuring sensitivity and pain thresholds] |
Q57638476 | [Treatment of asthmatic bronchitis in small children with steroid inhalation] |
Q57638118 | “To wheeze or not to wheeze”: That is not the question |
Q57638122 | “To wheeze or not to wheeze”: That is not the question—the sequel |
Search more.